GRASP MRI同时评估肝纤维化中的灌注与形态
本研究纳入64例计划行肝活检或切除的参与者,采用金角径向稀疏并行(GRASP)动态增强MRI,分别以12秒和3.3秒时间分辨率重建用于形态学评估和定量药代动力学建模。结果显示,F2-F3及F4期肝纤维化患者的门静脉血流量较F0-F1期显著降低,F4期动脉分数和细胞外容积显著升高;具有LR-M特征的肝细胞癌平均通过时间显著延长、动脉血流量显著降低。
要点
- GRASP DCE-MRI单次检查可同时获得满足形态学诊断的空间分辨率和用于药代动力学建模的高时间分辨率图像。
- F2-F3期门静脉血流量175±110 mL/100 mL/min、F4期98±47 mL/100 mL/min,均较F0-F1期283±178 mL/100 mL/min显著降低(p均<0.05)。
- LR-M特征肝细胞癌较非LR-M者平均通过时间显著延长、动脉血流量显著降低(p<0.05)。
核心结论
- GRASP肝脏MRI可同时获得足够空间分辨率用于可靠诊断和较高时间分辨率用于药代动力学建模;不同肝纤维化分期的MRI门静脉血流量存在显著差异,LR-M与非LR-M肝细胞癌的DCE-MRI定量参数不同。
研究设计与样本
- 前瞻性研究(NCT02480972),纳入计划行肝活检或切除的参与者,最终分析64例(男性48例)的DCE-MRI数据;图像以12秒时间分辨率重建用于形态学评估、以3.3秒时间分辨率重建用于定量评估;形态学图像质量采用四点量表评估,肝脏病灶记录LI-RADS评分。
关键影像表现/征象
- 形态学图像整体质量在整个检查过程中稳定在3.5±0.4至3.7±0.4。
- F2-F3期(n=18)门静脉血流量175±110 mL/100 mL/min、F4期(n=12)98±47 mL/100 mL/min,均较F0-F1期(n=34)283±178 mL/100 mL/min显著降低(p均<0.05)。
- F4期动脉分数和细胞外容积显著高于F0-F1期和F2-F3期(p<0.05)。
- 与非LR-M特征肝细胞癌(n=16)相比,LR-M特征肝细胞癌(n=5)平均通过时间显著延长、动脉血流量显著降低(p<0.05)。
诊断标准与关键数值
- 形态学图像质量采用四点量表评估。
- 肝脏病灶记录LI-RADS评分,并据LR-M特征分组比较DCE-MRI定量参数。
- 纤维化分期按F0-F1、F2-F3、F4分组比较门静脉血流量、动脉分数和细胞外容积。
临床应用与阅片要点
- 单次GRASP DCE-MRI检查即可同时提供用于解剖评估的形态学图像和用于药代动力学建模的高时间分辨率图像。
- 阅片时可结合门静脉血流量、动脉分数和细胞外容积等定量参数评估肝纤维化分期。
- 对肝细胞癌观察病灶的LR-M特征时,可参考平均通过时间和动脉血流量等DCE-MRI定量参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine if golden-angle radial sparse parallel (GRASP) dynamic contrast-enhanced (DCE)-MRI allows simultaneous evaluation of perfusion and morphology in liver fibrosis.
METHODS: Participants who were scheduled for liver biopsy or resection were enrolled (NCT02480972). Images were reconstructed at 12-s temporal resolution for morphologic assessment and at 3.3-s temporal resolution for quantitative evaluation. The image quality of the morphologic images was assessed on a four-point scale, and the Liver Imaging Reporting and Data System score was recorded for hepatic observations. Comparisons were made between quantitative parameters of DCE-MRI for the different fibrosis stages, and for hepatocellular carcinoma (HCCs) with different LR features.
RESULTS: DCE-MRI of 64 participants (male = 48) were analyzed. The overall image quality consistently stood at 3.5 ± 0.4 to 3.7 ± 0.4 throughout the exam. Portal blood flow significantly decreased in participants with F2-F3 (n = 18, 175 ± 110 mL/100 mL/min) and F4 (n = 12, 98 ± 47 mL/100 mL/min) compared with those in participants with F0-F1 (n = 34, 283 ± 178 mL/100 mL/min, p < 0.05 for all). In participants with F4, the arterial fraction and extracellular volume were significantly higher than those in participants with F0-F1 and F2-F3 (p < 0.05). Compared with HCCs showing non-LR-M features (n = 16), HCCs with LR-M (n = 5) had a significantly prolonged mean transit time and lower arterial blood flow (p < 0.05).
CONCLUSIONS: Liver MRI using GRASP obtains both sufficient spatial resolution for confident diagnosis and high temporal resolution for pharmacokinetic modeling. Significant differences were found between the MRI-derived portal blood flow at different hepatic fibrosis stages.
KEY POINTS: A single MRI examination is able to provide both images with sufficient spatial resolution for anatomic evaluation and those with high temporal resolution for pharmacokinetic modeling. Portal blood flow was significantly lower in clinically significant hepatic fibrosis and mean transit time and extracellular volume increased in cirrhosis, compared with those in no or mild hepatic fibrosis. HCCs with different LR features showed different quantitative parameters of DCE-MRI: longer mean transit time and lower arterial flow were observed in HCCs with LR-M features.
引用
- Yoon JH, Lee JM, Yu MH, et al. Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis. Eur Radiol. 2021. PMID: 34120229. doi:10.1007/s00330-021-08087-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。